Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 27, 2025 07:30 ET | Source: Aer Therapeutics

Aer Therapeutics to Participate at Cantor Global Healthcare Conference

DURHAM, N.C., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Aer Therapeutics (“Aer”), a biopharmaceutical company developing novel inhaled treatments for mucus-associated lung disease, announced today that...
January 08, 2025 07:30 ET | Source: Aer Therapeutics

Aer Therapeutics Announces First Patient Dosed in Phase 2 Clinical Trial of Fexlamose in Chronic Obstructive Pulmonary Disease

Study AER-01-002 is using a novel and precision imaging strategy to enroll 100 mucus plug-high chronic obstructive pulmonary disease (COPD) patients AER-01-002 is well powered to determine if 28-days...